Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report

Baltahi E., Altundag M., Onat D., Abbasoglu O., Ozisik Y., Guler N., ...More

TUMORI J, vol.88, no.6, pp.474-477, 2002 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 88 Issue: 6
  • Publication Date: 2002
  • Doi Number: 10.1177/030089160208800608
  • Journal Name: TUMORI J
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.474-477
  • Hacettepe University Affiliated: Yes


Aims and background: Sixty-three patients with local-regionally advanced breast cancer were treated with neoadjuvant chemotherapy consisting of docetaxel (Taxotere), epirubicin, and 5-fluorouracil (TEF).